SCHEMBL22645271

SCHEMBL22645271

Cc1cc(-c2ccc3c(c2)CC(=O)CN3)cn(C)c1=O

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 20/20 0.53
BRD9 Q9H8M2 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19869711 0.77 BRD4 (0.54) BRD4BRD9
SCHEMBL18497012 0.75 BRD4 (0.58) BRD4
SCHEMBL19869747 0.73 ASIC3 (0.52) BRD4BRD9
SCHEMBL19869753 0.73 BRD4 (0.49) BRD4BRD9
SCHEMBL19857677 0.72 BRD4 (0.55) BRD4BRD9
SCHEMBL27263483 0.71 BRD4 (0.54) BRD4BRD9
SCHEMBL19142112 0.71 PARP10 (0.42)
SCHEMBL18497022 0.70 BRD4 (0.58) BRD4
SCHEMBL24556579 0.69 BRD4 (0.73) BRD4BRD9
SCHEMBL19869845 0.68 BRD4 (0.50) BRD4BRD9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10836742-B2 N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals NEOMED INSTITUTE (CA) 2020-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10836742-B2 N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals BRD4, BRDT, BRD1 BRD4 1/4885BRD9 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.